Literature DB >> 2227595

Epithelial ovarian tumors of borderline malignancy.

L W Rice1, R S Berkowitz, S D Mark, D L Yavner, J M Lage.   

Abstract

Between January 1975 and January 1987, 80 patients underwent primary surgery at Brigham and Women's Hospital for epithelial ovarian tumors of borderline malignancy. Surgical staging revealed 52 (65%) patients with stage IA, 2 (2.5%) with stage IB, 10 (12.5%) with stage IC, 4 (5%) with stage II, 11 (13.8%) with stage III, and 1 (1.2%) with stage IV. All 37 patients with mucinous tumors had stage I disease, whereas 13 (33%) of 39 patients with serous tumors had stage II-IV disease. The mean sizes of mucinous and serous ovarian tumors were 18.7 and 10 cm, respectively. At initial surgery, 48 (60%) patients had a total abdominal hysterectomy with bilateral salpingo-oophorectomy and 16 (20%) had an oophorectomy. Sixteen (20%) patients underwent cystectomy, 6 (37.5%) of whom subsequently had an oophorectomy. All 10 patients treated by cystectomy alone have remained disease free. CA-125 levels were normal in 5 patients with stage I disease, but were elevated in 6 of 8 patients with more advanced tumors. Current disease status was determined in 72 patients (90%); 69 (95.8%) are alive and disease free, 1 (1.4%) patient is alive with tumor, and 2 (2.8%) patients died, free of disease.

Entities:  

Mesh:

Year:  1990        PMID: 2227595     DOI: 10.1016/0090-8258(90)90431-j

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

Review 1.  Management, prognosis and reproductive outcomes of borderline ovarian tumor relapse during pregnancy: from diagnosis to potential treatment options.

Authors:  Francesco Cosentino; Luigi Carlo Turco; Stefano Cianci; Francesco Fanfani; Anna Fagotti; Salvatore Gueli Alletti; Giuseppe Vizzielli; Salvatore Giovanni Vitale; Antonio Simone Laganà; Francesco Padula; Claudio Coco; Salvatore Pisconti; Giovanni Scambia
Journal:  J Prenat Med       Date:  2016 Jan-Jun

2.  Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms.

Authors:  F Levi; C La Vecchia; L Randimbison; V C Te
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

3.  Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.

Authors:  Toshiyuki Okumura; Etuo Muronosono; Masahiko Tsubuku; Yasuhisa Terao; Satoru Takeda; Masanori Maruyama
Journal:  J Ovarian Res       Date:  2018-09-03       Impact factor: 4.234

4.  The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.

Authors:  Chenyan Fang; Lingqin Zhao; Xi Chen; Aijun Yu; Liang Xia; Ping Zhang
Journal:  BMC Cancer       Date:  2018-11-21       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.